Right-to-try

Views & Analysis

The impact of the debate on the Right-to-Try laws in the US and what needs to be done to improve access to innovative drugs.

News

With $81.3 million raised, Vogenx is the latest in a staggering summer of biotech IPOs. But the queue past this point looks thin.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.